XENE Stock: Price, Earnings History and SEC Filings
Xenon Pharmaceuticals Inc. (XENE) last traded at $37.41, down 0.35% on the latest session and up 0.6% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-1.11 against an analyst estimate of $-1.16, a beat of 4.3%.
$37.41 -0.35%
1 month+0.59%
52-week high$72.66
52-week low$33.38
Volume1.12M
ExchangeNasdaqGM
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
XENE earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 6, 2026 | $-1.11 | $-1.16 | +4.31% |
| Mar 2026 | May 7, 2026 | $-1.17 | $-1.17 | +0.00% |
| Dec 2025 | Feb 26, 2026 | $-1.31 | $-1.20 | -9.17% |
| Sep 2025 | Nov 3, 2025 | $-1.15 | $-1.16 | +0.86% |
XENE beat the analyst EPS estimate in 2 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for XENE
SEC filing data is not available right now. You can search for XENE on SEC EDGAR.
XENE news
- Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Oct 30, 2026 · finance.yahoo.com
- Xenon Announces Positive Phase 1 and New Preclinical Data at IASP 2026 Supporting Advancement of XEN1701 and XEN1120 to Phase 2 Proof-of-Concept Studies in Acute PainOct 29, 2026 · finance.yahoo.com
- Inside the $1 Billion Blockbuster Opportunity Sending Rapport Therapeutics Stock HigherOct 20, 2026 · finance.yahoo.com
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc. (XENE) is a US-listed public company on Nasdaq.